India

in page functions
[French]
India
Total population (2018) 1,358,103,152
Birth cohort (2018) 25,701,683
Surviving Infants (surviving to 1 year per year, 2018) 24,848,076
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 38/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 48/1000
Gross Nation Income (per capita US$, 2015) 1,600
Co-financing group (2018) Accelerated transition
No. of districts/territories (2017) 700

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for India

Type of support

Approvals

2001-2022 (US$)
(20 Jul 2018)

Commitments

2001-2022 (US$)
(20 Jul 2018)

Disbursements

2000-2018 (US$)
(20 Jul 2018)

% Disbursed

(20 Jul 2018)
2002 2003 2005 2006 2007 2009 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021
Total $789,073,988 $914,401,285 $712,607,106
Health system strengthening (HSS 1) $107,000,000 $107,000,000 $107,000,000 100%
Health system strengthening (HSS 2) $53,979,703 $100,000,000 $26,465,953 49%
HepB mono (NVS) $26,486,033 $26,486,033 $26,486,033 100%
Injection safety support (INS) $18,427,489 $18,427,489 $18,427,489 100%
IPV (NVS) $16,319,169 $16,319,169 $16,319,169 100%
Measles-Rubella (NVS) $127,341,015 $127,341,015 $125,069,438 98%
MR - Operational costs (OPC) $8,508,020 $8,508,020 $7,032,885 83%
Penta (NVS) $264,904,036 $264,904,036 $264,904,712 100%
Pneumo (NVS) $109,749,000 $180,000,000 $109,717,890 100%
Rotavirus (NVS) $55,944,000 $65,000,000 $10,768,014 19%
Vaccine Introduction Grant (VIG) $415,523 $415,523 $415,523 100%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

India DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2017)

Grade of confidence


N/A
DTP3 - Official country estimates (2017) 88%
M:F sex ratio at birth (2018) 1.11
Household survey: DTP3 coverage for male (2008) 71.50%
Household survey: DTP3 coverage for female (2008) 71.40%
Household survey: Last DTP3 survey (2008) 72%
% districts achieving > 80% DTP3 coverage (2017) 61%
% districts achieving < 50% DTP3 coverage (2017) 2%
MCV WHO/UNICEF estimates (2017) 88%

Breakdown of support

Non-vaccine support Vaccine support
22% 78%
$159,341,850 $553,265,256

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to India

07 May 2018

Rwanda - FB Live

New management training for immunisation leaders kicks-off in Kigali

24 managers from five Gavi-supported countries will attend the first round of the nine-month programme.

02 February 2018

Senegal - Anuradha's blog

From adolescence to adulthood: collaborating for the future of global health

On World Cancer Day 2018, Gavi's Deputy CEO Anuradha Gupta looks at how focussing on adolescent health now could help prevent cancer and other non-communicable diseases for generations to come.

24 January 2018

Zipline Drone

Gavi joins World Economic Forum Center for the Fourth Industrial Revolution

New hub for global multi-stakeholder collaboration dedicated to maximising benefits and minimising risks of emerging technology will accelerate Gavi’s impact.

close icon

modal window here